Mark Lowdell

Mark Lowdell

atInmune Bio· In proxies 2022–2025

Pay in FY2025-19% from the year before · Inmune Bio stock -66.6% the same year

Mark Lowdell was paid $1.5M in FY2025 (Dec), down 19%. Inmune Bio stock fell 66.6% that year.

Pay$100 in the stock at the end of FY23 → $14
Pay is from the Summary Compensation Table of each Inmune Bio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Inmune BioPublic company · 4 yr
    • 2022 – Present · 4 yrStock in role -85%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?